ViCardia Therapeutics, Inc.
- Home
- Companies
- Medical / Health Care
- Pharmaceuticals
- ViCardia Therapeutics, Inc.
ViCardia Therapeutics, Inc.
ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies for treating heart failure (HF) involving mitochondrial dysfunction.
Company details
Find locations served, office locations.
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2017
